Latest News
Cerba Research Delivers Key Data for Clover’s phase 1 RSV-hMPV±PIV3 combination vaccines study
Closing Days on Public and National Holidays 2025
Viroclinics-DDL changes name to Cerba Research
The Acquisition of Viroclinics-DDL
Expansion of US Facility: Increased Capacity & Testing Capabilities
Cerba Research Awarded NIH Contract for Central Lab Services
A New Paradigm for Patient Recruitment: Leveraging Medical Laboratory Data for Patient Recruitment
Cerba Research Announces Time-Saving COVID-19 Exploratory Tools and NGS Advancements
